PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

STOXX dips

Thu, 10th Nov 2022 08:57

STOXX 600 down 0.2%

*

Eyes on U.S. CPI data

*

Bitcoin attempts to steady

*

Wall Street futures edge up

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at

STOXX DIPS (0852 GMT)

European shares kicked off the day just below parity as some well-received earnings releases helped offset angst ahead U.S. inflation numbers later on Thursday and turmoil in crypto world after the implosion of exchange FTX.

The pan-European STOXX 600 equity benchmark was last down 0.2%. Heavyweight London-listed drugmaker AstraZeneca rose 1% after cancer drug sales help it beat quarterly expectations and raised its full-year guidance.

Top gainers following results were takeaway food company Delivery Hero, brakes maker Knorr Bremse, utility Centrica and medical technology firm Convatec which rose between 5 and 11%.

The highly leveraged real estate sector was under pressure ahead of U.S. inflation data that could set the speed of future Fed rate hikes, and following disappointing results from German property group Leg Immobilien.

EUROPE HEADS SOUTH (0745 GMT)

Shares in Europe are heading for a lower open as investors remain nervous ahead of U.S CPI data that could help set expectations for the pace of future interest rate hikes by the Federal Reserve.

Crypto markets have attempted to stabilise, sending bitcoin up more than 6% after erasing more than one quarter of its value in the past three sessions, which could offer some support.

Investors however still fear spillover effects after crypto exchange Biance pulled out of a deal to bail out FTX.

So while EuroSTOXX 50 futures fell 0.6% and Asian shares tumbled overnight, U.S. equity futures managed to hold in positive territory after a sharp drop on Wednesday.

Earnings in Europe, meanwhile, continued to flow and could help limit losses. Traders called for gains in AstraZeneca, Domino's Pizza, WH Smith and Qinetiq following quarterly updates.

RED WAVE (0705 GMT)

The outcome of the U.S. midterm elections remains inconclusive - short of the Republican sweep some had expected.

The "red wave", however, showed up in markets. The S&P 500 fell 2% on Wednesday and the dollar seemed to catch a bid from a wave of cryptocurrency selling. Bonds rallied with the risk-averse mood, which opens the door for disappointment as U.S. inflation data comes into focus later on Thursday.

Economists expect the annual headline rate to fall to 8.0%, the lowest since February, and Fed funds futures imply the market is close to evenly split on whether the Fed hikes by 50 basis points or 75 bps in December.

Signs of stickiness could push pricing for a peak in rates of around 5% to something a bit higher and put a floor under the greenback.

Share markets fell around Asia, with MSCI's broadest ex-Japan index down 1%. European futures fell 0.6%.

Traders also have a keen eye on the unfolding disaster at crypto exchange FTX.

Bigger rival Binance has walked away from a bailout after due diligence, and as an executive at another rival, OKX, put it, there is a "dagger" over the market until the total damage is clear.

Key developments that could influence markets on Thursday:

U.S. CPI, ECB's Isabel Schnabel and Fed's Lorie Logan speak

Earnings: Zurich Insurance, RWE, Aegon , Delivery Hero, ArcelorMittal, Continental

More News
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.